EBON · Ebang International Holdings Inc.

Ebang International Holdings Inc. (EBON) reported FY2025 results showing revenue growth of 11.4% to $6.5 million from $5.9 million in FY2024, reflecting continued demand for products following the Company's strategic pivot from crypto mining into renewables and fintech applications. This topline expansion occurred despite broader market challenges, including supply chain disruptions and regulatory pressures on cross-border operations that have elevated business costs.

Gross profit fell sharply by 66.8% to $394.8 thousand, compressing the gross margin to 6.0% from prior levels. This contraction stems primarily from VAT recoverable impairments recognized within cost of revenues, as management determined these amounts would not be recoverable in the foreseeable future. Such non-cash charges highlight ongoing risks in tax recoverability and cost management within the Company's global supply chain, particularly as it maintains quality control systems essential to avoiding demand decreases or order cancellations due to certification lapses.

Operating expenses declined, contributing to a 16.7% improvement in the operating loss to -$25.3 million from -$30.4 million. This discipline in cost control—through reductions in selling and general and administrative expenses—demonstrates management's focus on efficiency amid impairments. The maximum output of in-house production facilities, dictated by SMT lines in Hangzhou and aligned with development strategy, remains a key capacity constraint influencing scalability.

The net loss narrowed significantly by 30.4% to -$14.1 million, with diluted EPS improving to -$2.24 from -$3.22. This progress reflects the combined impact of operating improvements and favorable non-operating items, positioning the Company for potential recovery as it navigates foreign exchange settlement flexibilities under SAFE regulations.

Cash flow from operations improved markedly, using only -$9.0 million versus -$17.6 million prior year, signaling enhanced working capital efficiency. However, free cash flow widened to -$13.5 million due to elevated capital expenditures of $4.5 million, up from $223 thousand. These investments target production facility expansions and intellectual property acquisitions like photomasks and molds, directly supporting anticipated business growth and output capacity enhancements. Management may further bolster liquidity through additional funding to sustain this trajectory amid regulatory and operational uncertainties.